NT5E and neoplasm: Targeting CD73 with specific antibodies inhibits cell migration and invasion [31], while the anti-CD73 antibody–drug conjugate (ADC) anti-CD73-PLG-MMAE shows elicited potent cytotoxicity and suppresses tumor growth [32].